Integrated immunoinformatics for the design of novel multi-epitope vaccine and identification of new drug targets against Stenotrophomonas maltophilia, a multidrug-resistant superbug
The designed MEV and identified immunogenic targets represent promising vaccine candidates against S. maltophilia, offering safer and more specific therapeutic avenues, and nine novel drug targets were predicted for S. maltophilia, providing new therapeutic insights.